Randox Laboratories

University of Geneva researchers in collaboration with the UK's Proteome Sciences have identified a protein marker that could help doctors better determine the time of stroke onset.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Proteome Sciences said today that it has signed a non-exclusive license with Randox Laboratories for use of its stroke protein biomarker portfolio.

Randox Laboratories has launched its Beta-Lactams Array.

Randox Laboratories this week launched its KRAS/BRAF/PIK3CA Array. The company said that clinicians can use the chip to select appropriate patients for colorectal cancer patients undergoing anti-EGFR therapy.

The offering is designed to complement the firm's menu of more focused screening tools.

The funding is for seven projects aimed at creating biomarkers to help guide patients to the most appropriate treatments and at creating drugs and companion diagnostics.

New Product Watch

Premium

Fluidigm's 192.24 Dynamic Array IFC, LC Sciences' V17 MicroRNA Microarrays, Arrayjet's Custom Microarray Services, Randox Laboratories' Quantiplasma Array

The Paris-based firms earlier this year announced a partnership to develop monoclonal antibody microarrays that combine BSI's antibodies with MBC's microarray platform.

New Product Watch

Premium

Gentel Biosciences' APiX Disease Profiling Kit, Randox Laboratories' Metabolic Syndrome Arrays

New Product Watch

Premium

Randox Laboratories, Ocimum Biosolutions, DNAVision, Illumina

Pages

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.